Why Reinsurance Leaders Misdiagnose Technology Supply-Chain Risk

The Hidden Concentration Risk Inside Shared Technology Supply Chains

A reinsurance portfolio can look perfectly diversified across geography and industry while quietly sharing the same handful of technology vendors underneath. That shared dependency is a concentration risk hiding in plain sight, and most underwriting processes are not built to see it.

What is a technology supply-chain dependency in a reinsurance portfolio?

It is the common thread of shared cloud, software, or service providers running underneath policies that otherwise look unrelated.

Two policyholders in different countries and different industries can both depend on the same cloud region, the same identity provider, or the same managed service provider. Neither underwriter reviewing those two accounts separately has any reason to notice the overlap. Moody's RMS has described this directly: losses can propagate "through shared technology dependencies that traditional portfolio views struggle to make visible." That invisibility is precisely what makes this risk different from risks underwriters are trained to spot.

Why do underwriters treat shared vendors as unrelated risks?

Because underwriting is structured account by account, not vendor by vendor.

Most underwriting files capture a policyholder's own controls and history, not a systematic record of which cloud provider, SaaS platform, or MSP sits behind their operations. Without that field captured consistently, there is no way to later query the book and ask which accounts share a common technology dependency. The earnings-volatility effect of technology supply-chain dependencies is a direct consequence of this gap in how exposure gets captured at binding. Fixing the diagnosis has to start with capturing the right data at the point of underwriting, not after a loss forces the question.

How did the CrowdStrike outage expose this blind spot?

By turning an obscure software update into a correlated loss event across thousands of organizations in a single day.

Guy Carpenter's analysis of the July 2024 event estimated insured losses "between $300 million and $1 billion" from the outage itself, and between $600 million and $2 billion under a hypothetical malicious version of the same scenario. Fewer than 1% of globally insured companies were directly exposed, yet the aggregate loss still reached into the hundreds of millions. That combination, a low individual hit rate with a large aggregate number, is the exact signature of a shared technology dependency risk. Portfolios that had never tagged vendor dependency discovered their true correlation only after the event had already happened.

Why do traditional aggregation models miss shared-vendor concentration?

Because they were built to catch geographic and line-of-business correlation, not technology-stack correlation.

A property catastrophe model correctly groups exposures by location, because that is where the physical peril concentrates. A shared technology dependency does not respect geography or line of business at all, cutting horizontally across an entire book instead. The Cloud Outage Impact AI Agent is built specifically to model this horizontal correlation, mapping dependency graphs rather than geographic proximity. Without a tool built for that specific shape of risk, most existing aggregation frameworks simply will not surface it.

How deep does dependency risk actually run below the hyperscaler layer?

Considerably deeper than most underwriting files currently account for.

Moody's RMS notes that portfolio exposure "may be shaped not only by dependence on the major hyperscalers but also by reliance on software and service providers that sit deeper in the technology stack." Their research cites the JLR cyberattack, which affected three UK plants directly but disrupted over 100,000 suppliers through cascading dependency. That scale of indirect exposure rarely shows up in any single underwriting file, because nobody asked the supplier's suppliers what they depend on. The Third-Party Cyber Risk AI Agent is designed to surface exactly this kind of layered, indirect dependency during underwriting.

Why does regulatory language now treat this as a systemic risk?

Because financial regulators have already concluded that shared technology reliance is a stability risk, not just an operational inconvenience.

The Bank of England and PRA have stated that "the increasing reliance on a small number of CSPs and other CTPs for vital services could increase financial stability risks in the absence of greater direct regulatory oversight." That language was written about the financial sector broadly, and it applies with equal force to reinsurers' own portfolios of insured technology dependency. Regulators reaching this conclusion before most underwriting teams have adjusted their process is itself a warning sign worth taking seriously. Waiting for a mandate to force this change is a slower and more expensive path than adapting ahead of it.

What makes this different from ordinary vendor risk?

Scale and simultaneity, which change how the loss actually behaves across a portfolio.

Treating every row in that table with the same single-account underwriting lens is exactly how the diagnosis gets missed.

Why do policyholders themselves often underestimate this dependency?

Most organizations can name their primary cloud provider but cannot name the sub-processors and managed service providers operating beneath it.

Underwriting submissions typically ask about first-tier technology relationships, which is also usually the limit of what a policyholder's own risk team tracks internally. That means even a well-intentioned, fully cooperative applicant often cannot supply the deeper dependency data underwriting would actually need. The gap is not dishonesty; it is that most organizations have never had a reason to map their own technology supply chain beyond the first layer. Reinsurers relying solely on policyholder self-reporting will inherit this same blind spot in their own portfolio view.

How does mergers and acquisitions activity change dependency concentration over time?

Vendor consolidation through M&A quietly raises portfolio concentration between renewals, even when no new business has been written.

When two previously separate technology vendors merge, every policyholder relying on either one now effectively depends on the same combined provider. Underwriting files rarely get updated to reflect this kind of change, since it happens on the vendor side rather than the policyholder side. A portfolio that looked well diversified at the last renewal can become meaningfully more concentrated purely through vendor market consolidation, without the reinsurer's own book changing at all. Monitoring vendor-market M&A activity is therefore part of keeping a concentration map current, not a separate exercise unrelated to underwriting.

How should this be factored into portfolio acquisitions or renewal rights deals?

Acquiring a book of business also means acquiring its hidden technology concentration, which should be assessed before the deal closes, not discovered afterward.

Acquired portfolios rarely come with vendor-dependency data already attached, since the selling organization may never have captured it either. Running the acquired accounts through existing concentration mapping tools before closing the deal reveals whether the acquisition adds genuine diversification or simply doubles down on an existing concentration point. Skipping this step means inheriting a blind spot that the acquiring organization did not create and may not discover until a shared vendor eventually fails.

Why do smaller and mid-sized reinsurers face this risk differently than the largest players?

Smaller reinsurers often have less negotiating leverage to demand vendor transparency from cedants, which makes this blind spot even harder to close in practice.

A large reinsurer with significant market share can more credibly ask cedants and brokers to supply detailed technology-dependency data as a condition of placement. A smaller or mid-sized reinsurer competing for the same business often cannot make that same demand without risking losing the placement to a less demanding competitor. This creates a structural disadvantage where the reinsurers with the least leverage to gather this data are often the ones who most need it, given their more concentrated books. Industry-wide standardization of technology-dependency disclosure would help level this gap, but until that exists, smaller players need to rely more heavily on their own portfolio-level monitoring tools instead of submission data alone.

What is the real diagnosis reinsurers keep missing?

That this is one large, correlated concentration exposure, not a collection of small, independent vendor risks.

Framing it as many small risks means each one looks immaterial on its own, and nobody escalates it. Framing it correctly, as a single concentration exposure sitting underneath the whole book, changes both the underwriting questions asked and the capital held against the answer. This reframing connects directly to the executive-level questions raised in what the executive committee must ask about technology supply-chain risk, and mirrors a similar diagnostic failure on the treaty-wording side of the book covered in the blind spot behind reinsurance underperformance from cyber event definitions. Getting the diagnosis right is the precondition for every governance and pricing decision that follows.

Technology supply-chain dependency is not a new category of risk so much as an old category, concentration risk, wearing a new disguise. Reinsurers that keep diagnosing it as scattered vendor risk will keep being surprised by how correlated their book actually was all along.

Sources

• Bank of England / PRA, "Operational resilience: Critical third parties to the UK financial sector" (CP26/23)
• CyberCube, "AWS Outage Highlights Systemic Risk from Cloud Concentration"
• Insurance Business Magazine, "CrowdStrike outage - how much did it cost the re/insurance industry?"